Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
One of the ways #FDA achieves its mission of protecting and promoting public health is by providing accurate, science-based information about medical products and foods. This week’s #SUNDAYTWEETORIAL highlights some of FDA’s many patient and consumer resources-It’s #NEWSYOUCANUSE https://t.co/Jamdv760GE
SteveFDA (R-D.C.)
@SGottliebFDA
@daviesbj Good luck with that Ben. But I hear Pittsburgh has a really good transplant program.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: FDA's Youth Tobacco Prevention Plan is a series of actions to stop youth use of tobacco products, especially e-ciga… https://t.co/auLKnjBJbE
SteveFDA (R-D.C.)
@SGottliebFDA
Looking to see if a drug has been approved by FDA, find approved therapeutic equivalents or view a drug label? Check out our Drugs@FDA database https://t.co/w36xuYK2mK or @NIH’s DAILYMED at https://t.co/Tc7lCQHTvj https://t.co/W5AZeyf8Ff
SteveFDA (R-D.C.)
@SGottliebFDA
We also maintain various databases for medical device approvals, denials and clearances https://t.co/ZpnSmuYIlo https://t.co/Yr9GagC4rg
SteveFDA (R-D.C.)
@SGottliebFDA
When a patient does not respond to current approved treatments, other options still may be available. For serious and life-threatening illnesses, some patients may want to talk to their doctor about trying an investigational medical product via a clinical trial or expanded access
SteveFDA (R-D.C.)
@SGottliebFDA
Clinical trials aim to answer Qs about safety or effectiveness of drugs and other therapies, or new ways to use existing treatments. While FDA doesn’t conduct clinical trials, we have tools to help you learn more and find a trial that may be right for you https://t.co/2kE1pd6DRj
SteveFDA (R-D.C.)
@SGottliebFDA
More information about expanded access programs is available at https://t.co/I3Ee0KkYXJ. We will be updating this site very soon to make it easier for patients and their families to navigate this program
SteveFDA (R-D.C.)
@SGottliebFDA
For important safety information and reporting serious problems with human medical products please visit MedWatch. At this site, you can report an adverse event and/or get important FDA safety information https://t.co/c8OQSCV1vn https://t.co/UVYyNr8yQs
SteveFDA (R-D.C.)
@SGottliebFDA
Looking for info on how to safely use certain drugs? Medication Guides are paper handouts that come with many prescription medicines and have FDA-approved info that can help patients avoid serious adverse events. Medication Guides can be found here https://t.co/ZhQwnl9qVj
SteveFDA (R-D.C.)
@SGottliebFDA
A drug recall is the best way to protect the public from a defective or potentially harmful product. A recall is a voluntary action taken by a company to remove a defective drug product from the market. Public voluntary recalls are listed here https://t.co/bYeyzHmInR
SteveFDA (R-D.C.)
@SGottliebFDA
FDA also monitors reports of adverse events & other problems with medical devices and alerts health professionals & the public when needed to ensure proper use of devices and health & safety of patients. For device recalls & safety communications, visit https://t.co/ZeY89eTgqc
SteveFDA (R-D.C.)
@SGottliebFDA
Drug Shortages happen for many reasons incl manufacturing & quality problems, delays & discontinuations. Manufacturers provide FDA most drug shortage info & we work closely with them to prevent or reduce the impact of shortages. Check our shortage database https://t.co/0QY05mcG0u
SteveFDA (R-D.C.)
@SGottliebFDA
Biological products include a wide range of products such as vaccines, blood & blood components, allergenics, somatic cells, gene therapy, tissues & recombinant therapeutic proteins. For info about the safety and availability of biological products, visit https://t.co/U70Y6cdxI2 https://t.co/2boeyzrNym
SteveFDA (R-D.C.)
@SGottliebFDA
Biological products that are demonstrated to be biosimilar to or interchangeable with an FDA-approved biological product can provide more treatment options, increase access and potentially reduces costs through competition. Learn more about biosimilars https://t.co/STIbvQm769
SteveFDA (R-D.C.)
@SGottliebFDA
Generic drugs are just as safe & effective as their brand-name counterparts & often cost less. To help educate patients about FDA’s rigorous review process, the economics of pricing, etc., FDA offers a range of educational materials about generics here https://t.co/M25fq2aeh5 https://t.co/9RAQSveetr
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA just launched an updated #Medication Guide Database that is easier to use on mobile devices and adds features like active ingredient and brand name search, plus faster updates to the database https://t.co/7l5DVdgZwW https://t.co/MZyiI8Bys0
SteveFDA (R-D.C.)
@SGottliebFDA
Vaccines undergo a rigorous FDA review of lab and clinical data to ensure their safety, efficacy, purity and potency. According to @CDCgov, vaccines have reduced preventable infectious diseases to an all-time low. For resources on vaccines, go to https://t.co/Rc2CWUhQuB
SteveFDA (R-D.C.)
@SGottliebFDA
FDA’s responsibilities include a variety of HIV/AIDS-related issues, including reviewing and overseeing areas related to drugs, biologics and medical devices for the prevention and treatment of HIV/AIDS-related conditions. Check out HIV info and resources https://t.co/mbOD7dazB4
SteveFDA (R-D.C.)
@SGottliebFDA
Stay informed about foodborne illness outbreaks linked to FDA-regulated food products. FDA’s Coordinated Outbreak Response and Evaluation (CORE) Network manages response, surveillance, and post-response activities https://t.co/TkX9uCx4oM https://t.co/21MUZYILjP